Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
Palm Beach, FL – January 19, 2023 – FinancialNewsMedia.com News Commentary – Gamma Delta T Cell Therapy represents one of the most promising T Cell therapies in clinical development. The introduction of T cell-based immunotherapy has greatly revolutionized the paradigm of cancer treatment. The progress in clinical research and innovation has led to the identification […]
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
Endeavor to focus on expanding understanding of gamma-delta T cells in oncological settings Edinburgh, Scotland – January 19, 2023 – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) (“TC Biopharm” or the “Company”) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer treatment, this week announces a strategic collaboration […]
